Come by the Winnipeg in 2023 parties, which I'm helping to organize.
I took an antigen test yesterday, taking another one today (it's one of the two-part tests) before I leave tomorrow. Bringing more (but not one per day) to the con. Over on Facebook I did advise everyone coming to test beforehand.
Wearing KF94 respirators (easier to source than N95, tested to be very, very good if worn correctly).
In any case, if we're going to "live with" SARS-CoV-2, then we desperately need to figure out how to prevent it from leading to debilitating conditions in large numbers of people.
Yeah--one of the reasons I have not commented extensively on this topic before is that the research studies were conflicting and all of similarly small size. The inclusion of 240,000 SARS-CoV-2-confirmed patients in this analysis gives me some feeling that it will be authoritative--though I do still emphasize the not-yet-reviewed caveat that applies to it and many of the studies on this topic.
Re: vaccine efficacy vs. Omicron, the concern I've seen expressed is that the immune response will prove to be not very durable. Peter Hotez has been in full-on panic mode given this prospect over the past couple of days. Too early to know for sure, of course, but it would seem to accord with the results seen in this study: https://www.medrxiv.org/content/10.1101/2021.12.07.21267432v1
While it's certainly too early to tell, you make a good point about the possibilities. I have a feeling that we are going to need to design and deploy an Omicron-specific booster shot eventually. Maybe sooner than eventually.
Enjoy your first WorldCon!
Have fun at WorldCon!
Come by the Winnipeg in 2023 parties, which I'm helping to organize.
I took an antigen test yesterday, taking another one today (it's one of the two-part tests) before I leave tomorrow. Bringing more (but not one per day) to the con. Over on Facebook I did advise everyone coming to test beforehand.
Wearing KF94 respirators (easier to source than N95, tested to be very, very good if worn correctly).
See you there, I hope.
There are now a small handful of studies on vaccination's effect (or lack thereof) on long COVID. Unfortunately, some find either no effect (see: https://www.medrxiv.org/content/10.1101/2021.10.26.21265508v1.full.pdf) or a much more modest one (see: https://www.researchsquare.com/article/rs-1062160/v1). A number of commentators have expressed skepticism that billing codes would adequately capture the phenomenon either way.
In any case, if we're going to "live with" SARS-CoV-2, then we desperately need to figure out how to prevent it from leading to debilitating conditions in large numbers of people.
Yeah--one of the reasons I have not commented extensively on this topic before is that the research studies were conflicting and all of similarly small size. The inclusion of 240,000 SARS-CoV-2-confirmed patients in this analysis gives me some feeling that it will be authoritative--though I do still emphasize the not-yet-reviewed caveat that applies to it and many of the studies on this topic.
Re: vaccine efficacy vs. Omicron, the concern I've seen expressed is that the immune response will prove to be not very durable. Peter Hotez has been in full-on panic mode given this prospect over the past couple of days. Too early to know for sure, of course, but it would seem to accord with the results seen in this study: https://www.medrxiv.org/content/10.1101/2021.12.07.21267432v1
While it's certainly too early to tell, you make a good point about the possibilities. I have a feeling that we are going to need to design and deploy an Omicron-specific booster shot eventually. Maybe sooner than eventually.